Assays conducted in Calu-3, Panc-1, SKMEL147, and MEL501 cell lines, representing lung adenocarcinoma, pancreatic adenocarcinoma, and melanoma, respectively, showed that HNRNPM loss resulted in growth inhibition (Figure 7A, B), similar to what we had observed with PCa. Here, HNRNPM is linked to melanoma.